Free Newsletter

FEATURES >> 10 largest U.S. patent losses | 15 top blockbuster contenders | Emerging pharma jobs

Related Topics >> FDA | birth control | Wyeth | FDA approval | Watson Pharmaceuticals

SPOTLIGHT: Wyeth sues Watson to quash generic

March 14, 2008 — 6:59am ET

Related Stories

Tools

It's Watson Pharmaceuticals and Wyeth in the ring, as Watson filed for FDA approval to sell a generic version of Lybrel, a birth control pill, and Wyeth responded by suing for patent infringement. Report, Report

SHARE
WITH:

More stories about Wyeth FDA approval Watson Pharmaceuticals FDA birth control

Paid Research Reports

More Research Reports >>